A clinical trial has found people prefer receiving information on the 5:2 diet than standard GP weight management advice despite both interventions achieving similar modest weight loss results.
The trial, funded by the Medical Research Council (MRC) and led by Queen Mary University of London, is the first randomised evaluation of the 5:2 diet, a popular type of intermittent fasting regime. Researchers studied the long-term effects of providing 5:2 diet instructions compared to traditional weight loss advice in 300 UK adults with obesity over a one-year period.
The findings show that long-term weight loss was similar for those who received 5:2 diet or standard weight management advice with 18 per cent and 15 per cent of participants respectively losing at least five per cent of their body weight at one year. However, when asked to rate each intervention, participants in the 5:2 diet group were more likely to recommend the intervention to others or be willing to continue with their diet.
Previous evidence suggests that peer support could be important for encouraging dieters to adhere to and realise the effects of the 5:2 diet. To test this, the researchers studied the impact of a weekly support group in addition to the simple 5:2 diet advice. They found that whilst initially face-to-face support generated better early effects and improved adherence to the 5:2 diet, these effects weakened over time.
Together, the findings suggest that providing brief advice on the 5:2 diet could extend the options clinicians can offer to patients.
Dr Katie Myers Smith, Chartered Health Psychologist and Senior Research Fellow at Queen Mary, said: “Here we’ve been able to provide the first results on the effectiveness of simple 5:2 diet advice in a real-life setting. We found that although the 5:2 diet wasn’t superior to traditional approaches in terms of weight loss, users preferred this approach as it was simpler and more attractive. Based on these findings, GPs may consider recommending the 5:2 diet as part of their standard weight management advice.”
The 5:2 diet is popular intermittent fasting weight loss intervention whereby dieters restrict their caloric intake on two non-consecutive days a week and then apply sensible eating on the remaining days. It first became popular in the UK through a BBC Horizon documentary and follow-up bestselling book.
In the study, traditional weight management advice on diet and exercise consisted of a 20-minute session where patients where an advisor explained the programme and went over key tips provided in supporting materials including the British Heart Foundation guides ‘Facts Not Fads’ and ‘Get Active, Stay Active’, the NHS ‘Change 4 Life’ series of booklets and a leaflet listing local resources for exercise. Participants in the 5:2 group instead received a leaflet on restricting their caloric intake on two non-consecutive days a week, with examples of meals containing the required amount of calories, and pointers to additional online support as part of an individual 20-minute session.
Notes to editors
For more information or a copy of the paper, please contact:
Sophie McLachlan
Faculty Communications Manager (Medicine and Dentistry)
Queen Mary University of London
About Queen Mary University of London
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
In 1785, Sir William Blizard established England's first medical school, The London Hospital Medical College, to improve the health of east London's inhabitants. Together with St Bartholomew's Medical College, founded by John Abernethy in 1843 to help those living in the City of London, these two historic institutions are the bedrock of the Faculty of Medcine and Dentistry.
Today, the Faculty of Medicine and Dentistry continues to uphold this commitment to pioneering medical education and research. Being firmly embedded within our east London community, and with an approach that is driven by the specific health needs of our diverse population, is what makes the Faculty of Medicine and Dentistry truly distinctive.
Our local community offer to us a window to the world, ensuring that our ground-breaking research in cancer, cardiovascular and inflammatory diseases, and population health not only dramatically improves the outcomes for patients in London, but also has a far-reaching global impact.
This is just one of the many ways in which Queen Mary is continuing to push the boundaries of teaching, research and clinical practice, and helping us to achieve the previously unthinkable.
###
PLOS ONE
Randomized controlled/clinical trial
People
A randomised controlled trial of the 5:2 diet
17-Nov-2021